Information  X 
Enter a valid email address

Reckitt Benckiser Gp (RB.)

  Print          Annual reports

Tuesday 12 May, 2020

Reckitt Benckiser Gp

Directorate Change

RNS Number : 6826M
Reckitt Benckiser Group PLC
12 May 2020
 

 

 

 

12 May 2020

 

RECKITT BENCKISER GROUP PLC

('RB' or 'the Company')

DIRECTORATE CHANGE

 

 

As previously announced, Warren Tucker did not stand for re-election as a Director at the Company's Annual General Meeting held on 12 May 2020, and stood down from the Board with effect from the conclusion of the meeting.  

 

As required by section 430 (2B) of the Companies Act 2006, it is confirmed that Mr Tucker will receive his pro-rata entitlement to non-executive director fees for the period up to 12 May 2020. Mr Tucker has not and will not receive any payments for loss of office.

 

 

For further Information:
Rupert Bondy

Company Secretary

Tel +44 (0) 1753 217 800

 

About RB

RB* is driven by its purpose to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. We fight to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.

 

RB is proud to have a stable of trusted household brands found in households in more than 190 countries. These include Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more.  20 million RB products a day are bought by consumers globally.

 

RB's passion to put consumers and people first, to seek out new opportunities, to strive for excellence in all that we do, and to build shared success with all our partners, while doing the right thing, always is what guides the work of our 40,000+ diverse and talented colleagues worldwide.

 

For more information visit  www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAGPURUAUPUGAP

a d v e r t i s e m e n t